Cellular apoptosis was measured using Caspase-Glo® 3/7 assay (Promega Corporation, Madison, WI, USA, Cat# G8091). Human cardiomyocytes were seeded as described above in an opaque white-walled 96-well plate. The next day, the cells were pre-treated with 500 nM ATRA, 1000 nM ATRA, or the vehicle (DMSO). After 24 hours, the cells were treated with the respective ATRA dose or vehicle (DMSO) and 0 or 10 μM doxorubicin concentration for another 24 hours. The 10 μM concentration of doxorubicin was selected based on the doxorubicin IC50 (half-maximal inhibitory concentration) measured in this study and to maintain physiological relevance [29, 30]. The assay was performed according to the manufacturer’s instructions and was read on POLARstar Omega plate reader (BMG Labtech) by measuring luminescence.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.